You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Valneva fast-tracks paediatric development of Lyme disease vaccine

French vaccine specialist Valneva has announced that it will accelerate the paediatric development of its Lyme disease vaccine candidate VLA15, which it is currently developing alongside pharma giant Pfizer.